دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 12,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 4,000,000 تومان- قیمت ویژه : 1,750,000تومان
Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets
Promoting a healthier Ramadan: addressing mind, body, soul, and heart wellbeing
Integration of a hypertension treatment programme into Nigeria’s primary healthcare system: report from a stakeholders and policymakers’ workshop
Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction
Management of aortic disease in children with FBN1-related Marfan syndrome
Great debate: myocardial infarction after cardiac surgery must be redefined
The DanGer Shock trial: a new dawn but much to uncover
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study
Achieving successful prevention of coronary artery disease: a worldwide call to action
Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial
Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world
TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation
Metabolites regulating chromatin accessibility: a piece of the puzzle
Cardiovascular disease risk communication alone is not enough: why a recent review may be misleading
Clearing up misunderstandings: addressing issues in recent cardiovascular risk review
Abdominal aortic penetration caused by an incidentally discovered inferior vena cava filter
‘Caterpillar-like’ pseudoaneurysms in Behçet’s disease
Correction to: Electrical storm treatment by percutaneous stellate ganglion block: the STAR study
